IgY-technology (egg yolk antibodies) in human medicine: a review of patents and clinical trials
IgY-technology (the production and extraction of specific IgY antibodies from egg yolk) is an innovative method to produce antibodies for therapy and prophylaxis. Advantages of IgY over other antibodies comprise its cost-effective extraction, the minimization of animal harm and distress, and its red...
| Autores principales: | , , , , |
|---|---|
| Formato: | Artículo |
| Lenguaje: | Inglés |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | http://hdl.handle.net/20.500.12123/6713 https://www.sciencedirect.com/science/article/pii/S1567576919323677 https://doi.org/10.1016/j.intimp.2020.106269 |
Ejemplares similares: IgY-technology (egg yolk antibodies) in human medicine: a review of patents and clinical trials
- IgY technology: producing antibodies from a 3Rs perspective
- Use of adjuvant ISA VG 71 to produce neutralizing egg yolk antibodies against bothropic venom
- In vivo neutralization of bee venom lethality by IgY antibodies
- IgY-based antivenom against Bothrops alternatus: Production and neutralization efficacy
- In vitro inhibitory activity of IgY antibodies against Salmonella ser. newport isolated from horses
- Anti-VP6 VHH : an experimental treatment for rotavirus A-associated disease